Reduced expression levels of antioxidants such as catalase, mitochondrial manganese superoxide dismutase (MnSOD), CuZnSOD, and reduced glutathione (GSH), not surprisingly, have been shown in human prostate cancer patient specimens, including tissue samples [27,28,29]. This evidence concerns the gene SOD2 and prostate carcinoma.